Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.20M | 6.61M | 3.33M | 2.09M | 3.51M |
| Total Receivables | 3.81M | 7.09M | 6.56M | 6.83M | 7.42M |
| Inventory | 117.20K | -- | -- | -- | -- |
| Prepaid Expenses | 42.70K | 103.50K | 130.40K | 172.50K | 124.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 887.60K | 46.80K | -- | 100.60K | 30.70K |
| Total Current Assets | 12.05M | 13.84M | 10.02M | 9.19M | 11.09M |
|
|
|||||
| Total Current Assets | 12.05M | 13.84M | 10.02M | 9.19M | 11.09M |
| Net Property, Plant & Equipment | 130.40K | 137.30K | 73.10K | 105.10K | 120.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.93M | 5.04M | 5.15M | 5.25M | 5.36M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 885.60K | 907.40K |
| Total Assets | 17.12M | 19.03M | 15.25M | 15.44M | 17.47M |
|
|
|||||
| Total Accounts Payable | 3.25M | 1.35M | 3.60M | 2.63M | 3.24M |
| Total Accrued Expenses | 1.11M | 1.96M | 816.60K | 667.10K | 954.40K |
| Short-term Debt | 619.00K | 300.50K | 615.60K | 599.90K | 300.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 205.90K | 72.50K | 9.60K | 23.90K | 38.70K |
| Total Finance Division Other Current Liabilities | 1.49M | 100.00 | 0.00 | 8.00K | 31.30K |
| Total Other Current Liabilities | 1.49M | 100.00 | 0.00 | 8.00K | 31.30K |
| Total Current Liabilities | 6.68M | 3.68M | 5.04M | 3.92M | 4.57M |
|
|
|||||
| Total Current Liabilities | 6.68M | 3.68M | 5.04M | 3.92M | 4.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 619.00K | 300.50K | 615.60K | 599.90K | 300.50K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.68M | 3.68M | 5.04M | 3.92M | 4.57M |
|
|
|||||
| Common Stock & APIC | 181.54M | 180.21M | 171.36M | 169.21M | 168.00M |
| Retained Earnings | -172.11M | -166.75M | -162.92M | -159.81M | -157.91M |
| Treasury Stock & Other | 2.05M | 2.83M | 2.52M | 2.63M | 3.14M |
| Total Common Equity | 11.48M | 16.29M | 10.96M | 12.03M | 13.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.48M | 16.29M | 10.96M | 12.03M | 13.24M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.04M | -944.30K | -756.10K | -515.60K | -327.50K |
| Total Equity | 10.44M | 15.35M | 10.20M | 11.51M | 12.91M |
|
|
|||||